An assessment of PCV13 vaccine coverage using a repeated cross-sectional household survey in Malawi

Background: The 13-valent pneumococcal conjugate vaccine (PCV13) was introduced in Malawi from November 2011 using a three dose primary series at 6, 10, and 14 weeks of age to reduce Streptococcus pneumoniae-related diseases. To date, PCV13 paediatric coverage in Malawi has not been rigorously asses...

Descripción completa

Detalles Bibliográficos
Autores principales: Bondo, Austin, Nambiar, Bejoy, Lufesi, Norman, Deula, Rashid, King, Carina, Masache, Gibson, Makwenda, Charles, Costello, Anthony, Rhoda, Dale, McCollum, Eric D., Colbourn, Tim
Formato: Online Artículo Texto
Lenguaje:English
Publicado: F1000 Research Limited 2018
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6266718/
https://www.ncbi.nlm.nih.gov/pubmed/30569035
http://dx.doi.org/10.12688/gatesopenres.12837.1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6266718/
https://www.ncbi.nlm.nih.gov/pubmed/30569035
http://dx.doi.org/10.12688/gatesopenres.12837.1

Ejemplares similares